POINT Biopharma Global Inc (PNT)


Stock Price Forecast

Nov. 17, 2023


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading POINT Biopharma Global Inc chart...

About the Company

a novel, research based biotechnology company focused on the development and commercialization of radiopharmaceutical products to meet unmet patient needs

CEO

Joe A. McCann

Exchange

NASDAQ

Website

pointbiopharma.com

$M

Total Revenue

132

Employees

$1B

Market Capitalization

88.21

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $PNT News

Here's Why You Should Add Lantheus (LNTH) to Your Portfolio

21h ago, source: Zacks.com on MSN

Lantheus Holdings, Inc. LNTH has been gaining from its focus on pipeline development. The optimism led by a solid ...

Astra to Buy Fusion Pharma in Hunt for New Cancer Treatments

on MSN ago, source:

AstraZeneca Plc agreed to buy Fusion Pharmaceuticals Inc. for as much as $2.4 billion as European drugmakers snap up ...

AstraZeneca-Fusion deal reignites radiopharma space

9d ago, source: Seeking Alpha

In December, Eli Lilly (LLY) closed its $1.4B acquisition of Point Biopharma Global (PNT), a biotech focused on radioligand ...

AstraZeneca buys Hamilton-based smart cancer drug maker Fusion Pharmaceuticals for $2-billion

9d ago, source:

Deal will be ‘good for Canada’ as buyer will keep and expand local manufacturing presence, former Fusion chairman says ...

12 Best Biotech Penny Stocks to Invest In

4d ago, source: InvestingChannel on MSN

In this article, we discuss the 12 best biotech penny stocks to invest in. If you want to skip our detailed analysis of these ...

Cue Biopharma gets grant for T-cell modulatory multimeric polypeptides for immune response modulation

22h ago, source: Pharmaceutical Technology

Discover Cue Biopharma's innovative T-cell modulatory polypeptides with a novel homodimer structure for therapeutic applications. Explore the potential of this patented technology for targeted and ...

Biopharma company to create 401 jobs in Wilson

on MSN ago, source:

The jobs would be part of a $371 million investment in Wilson County. The announcement came during a meeting of the state ...

2 More Potential Biotech Buyout Targets

3d ago, source:

M&A activity in the biotech/biopharma sector is expected to remain active due to significant cash on Big Pharma's balance ...

Sutro Biopharma files patent for antibody conjugates targeting CD74 for therapy

2d ago, source: Pharmaceutical Technology

Discover the latest patent by Sutro Biopharma Inc. for antibody conjugates targeting CD74, offering innovative therapy methods for cancer treatment. Explore the groundbreaking details now!

AstraZeneca bets on next-generation cancer therapy with $2 bln Fusion deal

9d ago, source: Reuters

March 19 (Reuters) - AstraZeneca (AZN.L), opens new tab said on Tuesday it will buy Canadian drug developer Fusion Pharmaceuticals Inc (FUSN.O), opens new tab ... cancer today receive radiotherapy at ...

Ardelyx Appoints Veteran BioPharma Executive, Mike Kelliher, as Executive Vice President, Corporate Development and Strategy

4d ago, source: Business Insider

March 25, 2024 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq ... expertise from leading biotechnology and global pharmaceutical companies. “This newly created position reflects the important inflection ...

Jessie J says she’s the opposite of a ‘beige mum’ as she shows off son’s playroom

23h ago, source:

Later, Jessie posted more on her stories about the room redesign.

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...